Suchergebnisse - "Cappello, Maria"

PubPharm (162)

21

Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease : data from the Sicilian Network for Inflammatory Bowel Disease

enthalten in: European journal of gastroenterology & hepatology | 2022

von Dipasquale, V. | Pellegrino, S. | Ventimiglia, M. | +9

22

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

enthalten in: The American journal of gastroenterology | 2022

von Onali, S. | Pugliese, D. | Caprioli, F. | +28

23

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG-IBD LIVE study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Pugliese, D. | Privitera, G. | Crispino, F. | +58

CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):731-732. - PMID 35879894

24

Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Cappello, M. | Crispino, F. | +18

25

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55

26

Molecular and Physiological Properties of Indigenous Strains of Oenococcus oeni Selected from Nero di Troia Wine (Apulia, Italy)

enthalten in: Microorganisms | 2022

von Cappello, M. | Falco, V. | Curcio, R. | +2

27

Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies : A Multicenter Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Calabrese, E. | Rispo, A. | Zorzi, F. | +21

CommentIn: Clin Gastroenterol Hepatol. 2022 Feb;20(2):472-473. - PMID 33839274

28

Effectiveness of adalimumab for ulcerative colitis : A multicentre, retrospective study of clinical practice in Italy

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Vitello, A. | Grova, M. | Pugliese, D. | +25

29

Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

enthalten in: Frontiers in medicine | 2022

von Marsal, J. | Barreiro-de Acosta, M. | Blumenstein, I. | +3

30

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG‐IBD LIVE study

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Pugliese, D. | Privitera, G. | Crispino, F. | +22